首页> 美国卫生研究院文献>Asian Journal of Andrology >MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery
【2h】

MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery

机译:MicroRNA在前列腺癌中的表达和功能:当前知识和发现机会的综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNAs (miRNAs) are well-conserved noncoding RNAs that broadly regulate gene expression through posttranscriptional silencing of coding genes. Dysregulated miRNA expression in prostate and other cancers implicates their role in cancer biology. Moreover, functional studies provide support for the contribution of miRNAs to several key pathways in cancer initiation and progression. Comparative analyses of miRNA gene expression between malignant and nonmalignant prostate tissues, healthy controls and prostate cancer (PCa) patients, as well as less aggressive versus more aggressive disease indicate that miRNAs may be future diagnostic or prognostic biomarkers in tumor tissue, blood, or urine. Further, miRNAs may be future therapeutics or therapeutic targets. In this review, we examine the miRNAs most commonly observed to be de-regulated in PCa gene expression analyses and review the potential contribution of these miRNAs to important pathways in PCa initiation and progression.
机译:MicroRNA(miRNA)是保存良好的非编码RNA,可通过编码基因的转录后沉默广泛调节基因表达。前列腺癌和其他癌症中miRNA表达失调暗示了它们在癌症生物学中的作用。此外,功能研究为miRNA对癌症起始和进展中几个关键途径的贡献提供了支持。对恶性和非恶性前列腺组织,健康对照和前列腺癌(PCa)患者之间的miRNA基因表达进行比较分析,以及侵略性较小和侵略性较高的疾病表明,miRNA可能是肿瘤组织,血液或尿液中的未来诊断或预后生物标志物。此外,miRNA可能是未来的治疗方法或治疗靶标。在这篇综述中,我们检查了在PCa基因表达分析中最常观察到的失调的miRNA,并综述了这些miRNA对PCa启动和进展中重要途径的潜在贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号